medicare and glp-1 coverage Drug Perspective by Stacie B. Dusetzina,

In the trial that pitted Foundayo against dapagliflozin, the highest dose of Foundayo reduced blood sugar levels by up to 1.7 percentage points versus 0.8 points for dapagliflozin, with 7.3% weight loss versus 3.0% In the third trial, which tested Foundayo on top of insulin glargine, blood sugar levels dropped up to 2.1 points versus 0.8 points for placebo plus insulin, with 6.1% weight loss versus a slight gain

2025 Jan 1;82(1):94-98

But heres the real challenge: Employers must balance short-term costs with long-term benefits

Vishesh Bharucha +2 more Table of Contents In todays busy life, many people are looking for easy or no effort ways for weight reduction